Daniel Aghion
Fortuna: 545 651 $ al 30/06/2026
Fortuna: 545 651 $ al 30/06/2026
Daniel Aghion is currently an Independent Director at Oramed Pharmaceuticals, Inc. since 2024.
Education history includes an undergraduate degree from the University of Michigan and a doctorate from Tel-Aviv University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 113.441 ( 0,28 % ) | 545 651 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director/Miembro de la Junta | 01/01/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oramed Pharmaceuticals, Inc.
Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.